HemAcure - Team
HemAcure - Team
HemAcure - Team

Scientific and Ethical Advisory Board

The HemAcure consortium is supported by an external Scientific and Ethical Advisory Board consisting of four experts in the field of haemophilia A, gene therapy and ethical concerns. The members will ensure a high standard of research and monitor the progress of the project by taking part in the annual meetings. Whenever appropriate, it will consult the consortium and make recommendations as to improve their performance.

 

Members

Eva-Bettina Bröcker

Prof. Eva-Bettina Bröcker, University of Würzburg, Würzburg, Germany

Eva-Bettina Bröcker is an immunologist, dermatologist, and dermatopathologist. From 1992 until 2011 she held the Full Professorship for Dermatology and Veneorology at the University of Würzburg, Germany and was Chair of the Department for Dermatology, Veneorology and Allergology at the University of Würzburg.
Her research focus is: tumor biology and tumor immunology; cutaneous autoimmune diseases; histopathology of skin diseases.
Furthermore, she is active in German research politics since about 25 years and holds the Chair of the Ethical Committee of the University of Würzburg since 2014.

 

David Lillicrap

Dr. David Lillicrap, Queen's University, Kingston, Ontario, Canada

David Lillicrap is a Professor in the Department of Pathology and Molecular Medicine at Queen's University in Canada. He is the recipient of a Canada Research Chair in Molecular Hemostasis. He is the Chair of the Research Committee of the World Federation of Hemophilia, and a member of the Council of the International Society on Thrombosis and Haemostasis. His research program focuses on three areas of molecular hemostasis: the pathobiology of von Willebrand factor, factor VIII immunology and the evaluation of novel gene and cell-based strategies for the treatment of hemophilia.

 

Johannes Oldenburg

Prof. Dr. med. Johannes Oldenburg, Haemophilia Center, University Clinic Bonn, Bonn, Germany

Johannes Oldenburg is Professor and Director of the Institute of Experimental Haematology and Transfusion Medicine and the Haemophilia Center, University Clinic Bonn, Germany. Since 1995, his research has focussed on molecular genetics of blood coagulation factors (focus in haemophilia), vitamin K pathway and he has published more than 350 articles in these fields.
Prof. Oldenburg is a reviewer for several Journals in the field of Haemostasis, Genetics and Pharmacogenetics and currently sits or has participated on the Editorial Boards of Blood, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Haematologica, Haemophilia, Annals of Hematology, Blood Coagulation and Fibrinolysis
Prof. Oldenburg is a Member of the Arbeitskreis Blut, German Health Ministry and was Co-Chairman of the Scientific Subcommittee on Factor VIII & IX of the ISTH. He is a member of the International Society of Thrombosis and Haemostasis (ISTH), American Society of Hematology (ASH), German Societies of Thrombosis and Haemostasis Research (GTH), German Society of Transfusion Medicine and Immunohaematology (DGTI), International Society of Blood Transfusion (ISBT), Society of Human Genetics (GfH), and European Association for Haemophilia and Allied Disorders (EAHAD).

 

Piercarla Schinco

Dr. Piercarla Schinco, Hemostasis/Thrombosis Unit and Haemophilia Centre, Turin, Italy

Dr. Piercarla Schinco is the Director of the Thrombosis & Hemostasis Unit at the University Hospital “Molinette” in Turin, Italy. She has also been Lecturer in Haemostasis and Laboratory Medicine at the Turin University Medical School since 1998 and Contract Professor at the Turin University Medical School since 2010. She is also a member of the European Association for Haemophilia and Allied Disorders and the Italian Association of Haemophilia Centre Directors.
Her main scientific interest is concentrated on haemophilia and its innovative treatments. She is Author or co-Author of more than 70 scientific publications mainly in the haemophilia field and has been acting as Principal Investigator in several national and international collaborative trials.

Search
Home
Top

HemAcure on @twitter

News Section

HemAcure is proud to be example in Roland Berger article about Regenerative...

Read more

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

Social Media

Follow us on Twitter! @HemAcure_EU